STARFIGHTERS SPACE INC.

Starfighters Space has signed a memorandum of understanding with The Bionetics Corporation to integrate and handle small payloads for missions aboard its F‑104 aircraft. Bionetics will carry out assembly, testing, integration and data analysis at its Space Life Sciences Lab at Cape Canaveral. The payloads are intended as pilot projects to determine equipment and service needs for future missions; both companies are active at the facility. » More on de.investing.com

Starfighters Space was added to the Russell 3000 effective Monday. The company operates a fleet of supersonic aircraft for hypersonic testing and is developing the air‑launched STARLAUNCH program with a planned suborbital rocket launch next year and orbital capability in 18–24 months. The stock completed its IPO in December 2025, is currently trading at $5.32 with a market capitalization of $235 million, and rose 27% after the inclusion, but is significantly below its 52‑week high over the past six months. According to filings, Starfighters has more cash than debt and a current ratio of 5.21. » More on de.investing.com

Starfighters Space will be added to the Russell 3000 Index at the start of trading on June 29, 2026. The company operates a fleet of seven mission-ready F-104 supersonic jets at Kennedy Space Center and provides airborne launch infrastructure for hypersonic, microgravity, and test and military missions. The index inclusion is expected to raise the company’s visibility with institutional investors and portfolio managers and is described by the company as a milestone. » More on de.investing.com